Trial intelligence / Profile preview

Ropivacaine vs Levobupivacaine for HTEA in Coronary Surgery

NCT00552864Phase 4Completed

Sponsor
Centro Cardiologico Monzino
Start
Jan 2003
Modality
Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
Countries
1
01

Overview

A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection, levobupivacaine in postoperative pain, sponsored by Centro Cardiologico Monzino. Started Jan 2003; status: completed.

02

Drugs

ropivacaine hydrochloride liposomal suspension injectionlevobupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00552864.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00552864.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call